Bavarian Nordic Stock Jumps on Revenue Beat, Mpox Vaccine Order

Shares of Bavarian Nordic are surging 12% in Danish trading after the company with the only approved mpox vaccine in the U.S. and Europe posted a quarterly revenue beat and announced a huge vaccine order.

• 
  Bavarian Nordic Shares Continue Higher After New Mpox Vaccine Order, Earnings Beat

  The Wall Street Journal
• 
  Bavarian gains after mpox order brings guidance to top end

  Bloomberg

5 Things to Know Before the Stock Market Opens

News of the day for August 22, 2024

Argentina Lithium Reports Geophysical Survey Adds Nearly 600 Hectares of Potential Brine Aquifer at Rincon West Project and Plans Additional Drilling

Argentina Lithium & Energy Corp. (TSXV: LIT) (FSE: OAY3) (OTCQX: LILIF), ("Argentina Lithium" or the "Company") announces the completion of geophysical surveys at its Don Fermin property (the "Property"), part of the Company's Rincon West lithium project in Salta Province, Argentina. The results of these deep-seeking geophysical studies expand the potential extent of conductive brine aquifers at the project by nearly 600 hectares and have provided targets for a new 6-hole drill program at the pr

Bavarian Nordic Shares Continue Higher After New Mpox Vaccine Order, Earnings Beat

Shares in Bavarian Nordic surged after the Danish Mpox vaccine maker received a new order and reported earnings that beat expectations.

• 
  Bavarian Nordic Stock Jumps on Revenue Beat, Mpox Vaccine Order

  Investopedia
• 
  Bavarian gains after mpox order brings guidance to top end

  Bloomberg

Swiss Re Maintains Target After Profit Beats Expectations

The Zurich-based reinsurer made a net profit of $996 million for the second quarter and said its performance benefited from disciplined underwriting, low natural-catastrophe claims and strong investment income.

Bavarian Nordic Announces First Half 2024 Results

COPENHAGEN, Denmark, August 22, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first half of 2024 and released its financial calendar for 2025. Revenue for the first half was DKK 2,259 million, and the operating profit (EBITDA) was DKK 441 million.Revenue from travel health increased by 15% to DKK 1,119 million and revenue from public preparedness was DKK 1,024 million, which is in line with the Company’s expectations. Other rev

Interim Report Q2 2024: Strong execution leading to 5% organic growth and margin expansion

Highlights GN executed strongly across the three divisions resulting in 5% organic revenue growth for the GroupThe Hearing division continued to gain significant market share leading to 10% organic revenue growth, resulting in 5.3 percentage point increase in the divisional profit margin supported by synergies and the successful ReSound Nexia roll-outThe Enterprise division continued its focused execution leading to -3% organic revenue growth in a stabilizing market. The divisional profit margin

Swedish Growth Companies With High Insider Ownership

The Swedish market has been experiencing notable growth, mirroring the broader trends seen across Europe where major stock indexes have posted strong gains amid hopes for interest rate cuts. In this context, identifying growth companies with high insider ownership can be particularly compelling, as it often signals confidence from those closest to the business and aligns well with current positive economic sentiment.

Alpine 4 Holdings, Inc. Announces Receipt of Nasdaq Staff Determination Letter

PHOENIX, AZ / ACCESSWIRE / August 21, 2024 / Alpine 4 Holdings, Inc. (NASDAQ:ALPP) (the "Company"), announced today that on August 16, 2024, the Company received an Additional Staff Determination letter (the "August 16 Letter") from The Nasdaq Stock ...